Isolation of a pair of potent broadly neutralizing mAb binding to RBD and SD1 domains of SARS-CoV-2
Duyvesteyn, H.M.E., Screaton, G., Ren, J., Stuart, D.I., Fry, E.E.(2023) Res Sq 
Experimental Data Snapshot
wwPDB Validation   3D Report Full Report
(2023) Res Sq 
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Spike glycoprotein,Fibritin | 1,285 | Severe acute respiratory syndrome coronavirus 2, Tequatrovirus T4 This entity is chimeric | Mutation(s): 31  Gene Names: S, 2, wac | ||
UniProt | |||||
Find proteins for P0DTC2 (Severe acute respiratory syndrome coronavirus 2) Explore P0DTC2  Go to UniProtKB:  P0DTC2 | |||||
Find proteins for P10104 (Enterobacteria phage T4) Explore P10104  Go to UniProtKB:  P10104 | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Groups | P0DTC2P10104 | ||||
Glycosylation | |||||
Glycosylation Sites: 12 | Go to GlyGen: P0DTC2-1 | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
BA.2-07 FAB HEAVY CHAIN | 231 | Homo sapiens | Mutation(s): 0  | ||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 3 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
BA.2-07 FAB LIGHT CHAIN | E, G, I [auth L] | 214 | Homo sapiens | Mutation(s): 0  | |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 4 | |||||
---|---|---|---|---|---|
Molecule | Chains | Length | 2D Diagram | Glycosylation | 3D Interactions |
2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | J [auth I], K [auth J], L [auth K], M, N, J [auth I], K [auth J], L [auth K], M, N, O, P, Q, R, S, T, U | 2 | N-Glycosylation | ||
Glycosylation Resources | |||||
GlyTouCan:  G42666HT GlyCosmos:  G42666HT GlyGen:  G42666HT |
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
NAG Query on NAG | AA [auth A] BA [auth A] CA [auth A] DA [auth B] EA [auth B] | 2-acetamido-2-deoxy-beta-D-glucopyranose C8 H15 N O6 OVRNDRQMDRJTHS-FMDGEEDCSA-N |
Task | Software Package | Version |
---|---|---|
RECONSTRUCTION | cryoSPARC | |
MODEL REFINEMENT | PHENIX |
Funding Organization | Location | Grant Number |
---|---|---|
Wellcome Trust | United Kingdom | 203141/A/16/Z |
Wellcome Trust | United Kingdom | 101122/Z/13/Z |
Chinese Academy of Sciences | China | 2018-I2M-2-002 |
Medical Research Council (MRC, United Kingdom) | United Kingdom | MR/N00065X/1 |